Nasal flu vaccine for children in daycare
Part of Infections, Lungs & breathing clinical trials.
This trial is testing a nasal spray flu vaccine given to children at their daycare or a healthcare facility. It aims to make getting the vaccine easier and more convenient for families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child attends daycare in the city of Turku
- No other specific health requirements
- This trial is open to all children in Turku daycare
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether training students as vaccine ambassadors can improve vaccine education in schools. It may help increase vaccine knowledge and uptake among students.
This study tests if a new nasal spray flu vaccine is safe and effective for preventing flu in healthy adults aged 18 to 59. If you've had the flu recently or have certain health conditions, this trial may not be for you.
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
This study tests whether giving the nasal flu spray (Flumist) at home to families makes it easier for more people to get vaccinated. You and your family can participate if you live in Burlington, have a child aged 2-17, and haven't had the flu shot in the last 2 years.
This study tests how healthy adults respond to the nasal flu vaccine. You may be able to help researchers learn more about how the body reacts to this vaccine.
This trial tests a new oral medicine (JKN2301) for children with the flu. It aims to see if the medicine is safe and works well to treat flu symptoms like fever and cough.
Hear when a new Influenza Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.